Exagen (XGN) Return on Capital Employed (2019 - 2025)
Exagen (XGN) has disclosed Return on Capital Employed for 7 consecutive years, with 0.3% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 14.0% year-over-year to 0.3%, compared with a TTM value of 0.3% through Dec 2025, up 14.0%, and an annual FY2025 reading of 0.38%, down 1.0% over the prior year.
- Return on Capital Employed was 0.3% for Q4 2025 at Exagen, down from 0.26% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.14% in Q2 2021 and bottomed at 0.61% in Q3 2023.
- Average Return on Capital Employed over 5 years is 0.38%, with a median of 0.4% recorded in 2024.
- The sharpest move saw Return on Capital Employed crashed -35bps in 2023, then increased 21bps in 2024.
- Year by year, Return on Capital Employed stood at 0.21% in 2021, then plummeted by -164bps to 0.55% in 2022, then grew by 11bps to 0.49% in 2023, then grew by 8bps to 0.45% in 2024, then surged by 32bps to 0.3% in 2025.
- Business Quant data shows Return on Capital Employed for XGN at 0.3% in Q4 2025, 0.26% in Q3 2025, and 0.36% in Q2 2025.